EQ · Equillium, Inc. · Documents
Market Cap
$86.23M
Shares
63.41M
Volume · Oct 28
227.36K
Avg daily vol (3M)
579.9K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Equillium dosed the first subject in its Australian Phase 1 clinical trial of EQ504 on October 26, 2026, triggering a Milestone Closing that produced $20.0 million in aggregate gross proceeds. | 2026-10-26 | — | |
| 8-K | Equillium, Inc. received ethics approval and Australian clearance for its Phase 1 trial of EQ504, a randomized, double-blinded, placebo-controlled study expected to dose healthy participants by early November 2026. | 2026-10-05 | — | |
| 10-Q | — | 2026-08-13 | 2026-06-30 | |
| 8-K | — | 2026-08-13 | — | |
| 8-K | — | 2026-05-29 | 2026-05-28 | |
| 8-K | — | 2026-05-13 | — | |
| 10-Q | — | 2026-05-13 | 2026-03-31 | |
| DEF 14A | — | 2026-04-15 | 2026-05-28 | |
| DEFA14A | — | 2026-04-15 | — | |
| ARS | — | 2026-04-15 | 2025-12-31 | |
| S-3 | — | 2026-04-07 | — | |
| PRE 14A | — | 2026-03-30 | 2026-05-28 | |
| 10-K | — | 2026-03-25 | 2025-12-31 | |
| 8-K | — | 2026-03-25 | — | |
| 8-K | — | 2026-03-13 | 2026-03-11 | |
| S-3 | — | 2025-11-13 | — | |
| 10-Q | — | 2025-11-13 | 2025-09-30 | |
| 8-K | — | 2025-11-13 | — | |
| 8-K/A | — | 2025-10-24 | 2025-09-30 | |
| 8-K | — | 2025-10-06 | 2025-09-30 | |
| 8-K | — | 2025-09-19 | — | |
| S-3 | — | 2025-09-09 | — | |
| 8-K | — | 2025-09-04 | 2025-08-29 | |
| 10-Q | — | 2025-08-14 | 2025-06-30 | |
| 8-K | — | 2025-08-11 | 2025-08-10 | |
| 8-K | — | 2025-08-04 | 2025-08-03 | |
| 8-K | — | 2025-06-13 | 2025-06-12 | |
| 8-K | — | 2025-05-22 | 2025-05-21 | |
| 10-Q | — | 2025-05-14 | 2025-03-31 | |
| DEFR14A | — | 2025-04-30 | — | |
| 8-K | — | 2025-04-24 | — | |
| DEFA14A | — | 2025-04-10 | — | |
| DEF 14A | — | 2025-04-10 | 2025-05-21 | |
| ARS | — | 2025-04-10 | 2024-12-31 | |
| PRE 14A | — | 2025-03-28 | 2025-05-21 | |
| 10-K | — | 2025-03-27 | 2024-12-31 | |
| 8-K | — | 2025-03-27 | — | |
| 8-K | — | 2025-02-06 | — | |
| 8-K | — | 2024-12-13 | — | |
| 8-K | — | 2024-12-12 | 2024-12-10 | |
| 8-K | — | 2024-11-13 | — | |
| 10-Q | — | 2024-11-13 | 2024-09-30 | |
| 8-K | — | 2024-10-31 | 2024-10-30 | |
| 8-K | — | 2024-10-31 | 2024-10-30 | |
| 10-Q | — | 2024-08-08 | 2024-06-30 | |
| 8-K | — | 2024-08-08 | — | |
| 8-K | — | 2024-07-23 | 2024-07-19 | |
| 8-K | — | 2024-07-18 | — | |
| 8-K | — | 2024-06-04 | — | |
| 8-K | — | 2024-05-23 | 2024-05-22 |
Showing 1–50 of 152 filings